The data presented here suggest that measurement of BDNF/pro‐BDNF ratio and tPA/PAI‐1 ratio in biological fluids (serum, plasma, CSF), in association with neuroimaging data and neuropsychological characterization, may serve as indirect indicators of the “synaptic state” in the brain of AD subjects. The gene discussed is BDNF; the disease is Alzheimer disease.